For example, dysregulation of GALNT1 contributes to the malignant progression of hepatocellular carcinoma by modifying glycosylation of the epidermal growth factor receptor (EGFR), a member of receptor tyrosine kinase (RTK) family [13]. Here, GALNT1 is linked to hepatocellular carcinoma.